NDC 0310-0625 – Koselugo

Selumetinib 25 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC0310-0625

Product details

Brand name
Koselugo
Generic name
Selumetinib
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA213756
Marketed since
April 16, 2020
Listing expires
December 31, 2027
Pharmacologic class
Kinase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Koselugo →

Package NDC codes (2)

Package NDCDescriptionSince
0310-0625-2828 CAPSULE in 1 BOTTLE (0310-0625-28)Jun 11, 2021
0310-0625-6060 CAPSULE in 1 BOTTLE (0310-0625-60)Apr 16, 2020

Other Koselugo products